Skip to content

Author

B. Waldrup

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access 2026

Health Literacy and Colorectal Cancer: A Scoping Review Across the Cancer Care Continuum.

IntroductionHealth literacy is increasingly recognized as a critical determinant of cancer prevention, treatment adherence, and survivorship outcomes. In colorectal cancer (CRC), disparities in health literacy, particularly among ethnic minority and underserved populations, may contribute to reduced screening uptake, s...

N. P. Tjader, B. Waldrup, Juliana G. Barnard et al. · 0 citations
Oct 2026

Abstract C098: Integrative multi-omics profiling reveals genomic ancestry-associated molecular features of early-onset colorectal cancer

Colorectal cancer (CRC) remains the second leading cause of cancer-related mortality in the United States, with early-onset colorectal cancer (EOCRC) increasing at an alarming rate. Populations underrepresented in molecular oncology studies continue to experience disparities in CRC incidence and clinical outcomes...

F. Carranza, B. Waldrup, S. Manjarrez et al. · 0 citations
Sep 2026

Abstract A067: Precision medicine-oriented analysis of RTK-RAS signaling in gemcitabine-treated pancreatic cancer using conversational artificial intelligence

Although KRAS mutations represent the hallmark genomic alteration in pancreatic ductal adenocarcinoma (PDAC), the broader receptor tyrosine kinase RTK-RAS signaling landscapes underlying differential responses to gemcitabine remain poorly defined. We performed an integrative clinical-genomic analysis of 15...

C. Cosme, B. Waldrup, F. Carranza et al. · 0 citations
Sep 2026

Abstract A066: Toward early detection of pancreatic cancer: Somatic genomic profiling of early- and late-onset PDAC in a diverse cohort

The incidence of early-onset pancreatic ductal adenocarcinoma (EO-PDAC) is increasing, yet its molecular characteristics remain poorly defined. Improved understanding of genomic alterations associated with EO-PDAC may facilitate the discovery of biomarkers for earlier detection and precision oncology. We aimed to...

B. Waldrup, F. Carranza, S. Manjarrez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.